KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Goodwill & Intangibles (2020 - 2025)

Clover Health Investments' Goodwill & Intangibles history spans 6 years, with the latest figure at $3.0 million for Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed 0.0% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $3.0 million, changed 0.0%, while the annual FY2024 figure was $3.0 million, 0.0% changed from the prior year.
  • Goodwill & Intangibles reached $3.0 million in Q3 2025 per CLOV's latest filing, roughly flat from $3.0 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $20.0 million in Q4 2022 to a low of $3.0 million in Q4 2023.
  • Average Goodwill & Intangibles over 5 years is $7.0 million, with a median of $4.2 million recorded in 2021.
  • Peak YoY movement for Goodwill & Intangibles: skyrocketed 372.48% in 2022, then plummeted 85.05% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $4.2 million in 2021, then soared by 372.48% to $20.0 million in 2022, then tumbled by 85.05% to $3.0 million in 2023, then changed by 0.0% to $3.0 million in 2024, then changed by 0.0% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Goodwill & Intangibles are $3.0 million (Q3 2025), $3.0 million (Q2 2025), and $3.0 million (Q1 2025).